about
Improving pancreatic cancer diagnosis using circulating tumor cells: prospects for staging and single-cell analysisNeoadjuvant therapy for localized pancreatic cancer: guiding principlesImaging preoperatively for pancreatic adenocarcinomaSurgical treatment for advanced pancreatic cancerMolecular Imaging of Pancreatic Cancer with Antibodies.Radiation dose ≥54 Gy and CA 19-9 response are associated with improved survival for unresectable, non-metastatic pancreatic cancer treated with chemoradiation.Vascularisation pattern of chronic pancreatitis compared with pancreatic carcinoma: results from contrast-enhanced endoscopic ultrasound.Intensity of follow-up after pancreatic cancer resectionCombining Bevacizumab with Radiation or Chemoradiation for Solid Tumors: A Review of the Scientific Rationale, and Clinical Trials.Detecting circulating tumor material and digital pathology imaging during pancreatic cancer progression.Trajectory of care and use of multimodality therapy in older patients with pancreatic adenocarcinoma.High-quality endoscopic ultrasound-guided fine needle aspiration tissue acquisition.Pancreatic cancer-improved care achievableOverexpression of GOLPH3 is associated with poor prognosis and clinical progression in pancreatic ductal adenocarcinoma.Targeted screening of individuals at high risk for pancreatic cancer: results of a simulation modelA qualitative study of patient and clinician attitudes regarding surveillance after a resection of pancreatic and peri-ampullary cancer.Improving the results of pancreatic endoscopic ultrasound-guided fine needle aspiration in daily practice: keep it simple.Early recurrence of pancreatic cancer after resection and during adjuvant chemotherapy.Pre-treatment carbohydrate antigen 19-9 does not predict the response to neoadjuvant therapy in patients with localized pancreatic cancerPancreatic cancer: current standards, research updates and future directionsPreoperative serum CA125 levels predict the prognosis in hyperbilirubinemia patients with resectable pancreatic ductal adenocarcinomaDevelopment and validation of a symptom index for advanced hepatobiliary and pancreatic cancers: the National Comprehensive Cancer Network Functional Assessment of Cancer Therapy (NCCN-FACT) Hepatobiliary-Pancreatic Symptom Index (NFHSI).The clinical usefulness of 18F-fluorodeoxyglucose positron emission tomography-computed tomography (PET-CT) in follow-up of curatively resected pancreatic cancer patientsIncreased organ sparing using shape-based treatment plan optimization for intensity modulated radiation therapy of pancreatic adenocarcinoma.Improved survival after palliative resection of unsuspected stage IV pancreatic ductal adenocarcinoma.Final analysis of a phase II study of modified FOLFIRINOX in locally advanced and metastatic pancreatic cancer.Loss of phosphatase and tensin homolog expression is associated with recurrence and poor prognosis in patients with pancreatic ductal adenocarcinoma.Expression of Glut-1 and HK-II in Pancreatic Cancer and Their Impact on Prognosis and FDG Accumulation.The Association Between Chemoradiation-related Lymphopenia and Clinical Outcomes in Patients With Locally Advanced Pancreatic Adenocarcinoma.Prognostic significance of positive peritoneal cytology in resectable pancreatic cancer: a systemic review and meta-analysis.Advanced-stage pancreatic cancer: therapy options.Patient and physician views of shared decision making in cancer.Expression and prognosis value of SHP2 in patients with pancreatic ductal adenocarcinoma.Outcomes of a Clinical Pathway for Borderline Resectable Pancreatic Cancer.Changing trends in tissue acquisition in malignant pancreatic neoplasms.MicroRNA-186 affects the proliferation of tumor cells via yes-associated protein 1 in the occurrence and development of pancreatic cancerDiagnostic Accuracy of a CA125-Based Biomarker Panel in Patients with Pancreatic Cancer: A Systematic Review and Meta-Analysis.The implications of positive peritoneal lavage cytology in potentially resectable pancreatic cancer.Covered self-expandable metal stent deployment promises safe neoadjuvant chemoradiation therapy in patients with borderline resectable pancreatic head cancer.Prevalence and outcomes of cystic lesions of the transplant pancreas: The University of Wisconsin Experience.
P2860
Q26782719-7B5BCDFC-A142-4FB2-AD30-1EBDE646628AQ26799428-D3D1786B-68D4-4267-98E3-B60A87F90A66Q26799450-1A8E704F-BB0D-402F-B087-1437A2DB169EQ27003396-546D5ACD-5BE9-41A4-86F8-5390678AF347Q30393523-D327D3FD-B9DF-46EF-B87A-C782626CEC12Q30423279-62D633C7-E791-481C-8A9A-18994D698E07Q30465459-0EDC99EA-61DB-4D20-821F-4C42198651D8Q33791048-4417D6CD-300A-40F3-B10C-8BDBA91432B2Q33802617-7FF76DD2-0391-4BC7-B562-34C84126418CQ33803923-A385BCEF-91D0-4B47-8C9F-389694CD5C79Q33905392-1B0AFA89-D98B-4F23-968E-FD14E7E978D1Q33970078-F273E009-85BA-45AB-90A7-FF6C7162990EQ34036659-376F92A8-556F-4D69-81F8-00727C0ABE04Q34048461-A852F2E0-AA47-4F64-8CD6-4B780A098188Q35214109-7F448C8C-8024-4639-99A8-A386ECA7B73CQ35469061-868C8F5B-7311-4078-BB47-CBB12764DA65Q35768479-0B90B909-7BCC-407C-9FF1-E2A1D3358340Q35890548-AA0E5CCC-EE6A-4274-8F85-F177F1F093FBQ36064780-4B52B94E-5383-45AE-8F9D-A6CF1D99870EQ36097184-43F4ED3F-C3F3-4E08-8209-9A0D5156E30BQ36151583-B0B8DFB1-5676-446F-8640-B8A9FA92FD29Q36179711-13E09AD2-E2A2-4828-83C6-A9954929DE2BQ36570306-E254B702-5BBE-4CFD-B4E0-98ECBA20A483Q36626546-DE129A75-EAB7-4126-8ACA-1A8ECDD24EE4Q36747372-DBE17074-DD6E-4E65-AD0E-1BC9F622F966Q37174939-3285AFED-3CDA-4789-801F-7E1E4DEEDCF9Q37322384-90C783E4-A732-46A2-B4E6-959523ACE1A4Q37482653-1783954F-7395-4599-9123-1CBE35621575Q37710295-72785C90-6248-495B-986A-317988F78E81Q37716482-C07D595F-CDD4-4A78-9CA4-B718A530A2F4Q38102914-E063F372-D413-4177-BC87-A5E051B56051Q38808591-A49A7509-D927-4F81-BDAD-F625DE7A81CBQ40180313-CDF471CE-6367-48F4-9896-4E28B4402F8BQ40217786-2412E32D-3A81-4602-860B-797758E411A5Q40303365-1DDA8176-4177-4214-B1EE-D99CC6AD5A85Q41672310-F995C281-4E64-4486-8D73-8896C5CA13CDQ43565999-47BFCC2F-4900-4BE6-8414-1A77BC8F37A1Q44296948-3F76D1BA-9E2D-41A9-84E5-B0D64255D89AQ46689245-133F9387-2535-4249-9672-97D62C7019C0Q47245363-173BD771-AD2C-46BA-AE0A-7CEF69C8C0B4
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Pancreatic adenocarcinoma
@ast
Pancreatic adenocarcinoma
@en
type
label
Pancreatic adenocarcinoma
@ast
Pancreatic adenocarcinoma
@en
prefLabel
Pancreatic adenocarcinoma
@ast
Pancreatic adenocarcinoma
@en
P2093
P2860
P356
P1476
Pancreatic adenocarcinoma
@en
P2093
Aaron R Sasson
Al B Benson
Boris W Kuvshinoff
Christopher Willett
Douglas S Tyler
Ephraim S Casper
Eric K Nakakura
J Pablo Arnoletti
John L Cameron
John P Hoffman
P2860
P304
P356
10.6004/JNCCN.2010.0073
P577
2010-09-01T00:00:00Z